Ticker League

Tango Therapeutics (TNGX) Free Cash Flow Bridge

Pinpoint what moved Tango Therapeutics's free cash flow from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

TTM

FCF YoY

-4.85%

OCF YoY

-4.59%

Capex Change

+385.0K

FCF Conversion Δ

Free cash flow bridge for Tango Therapeutics (TNGX) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: −$6.59M

FCF bridge breakdown for Tango Therapeutics (TNGX) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow−$135.95M
  • Operating Cash Flow−$6.21M
  • Capital Expenditure−$385.00K
  • Free Cash Outflow−$142.54M
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation